Clinical study of adjuvant immuno-cell therapy for pancreatic cancer curatively resectable.
Not Applicable
- Conditions
- Pancreatic cancer
- Registration Number
- JPRN-C000000414
- Lead Sponsor
- Yokohama City University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who have: uncontrolled infections, active autoimmune diseases, and serious cardiac disease; who have received continuous systemic steroids; who are pregnant, to be pregnant, or nursing mothers, and whom principle investigator or co-investigator judged to be inappropriate to participate in this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relapse-free survival rate of relapse
- Secondary Outcome Measures
Name Time Method Safety Overall survival QOL(KPS) Immunological parameter